WHO ICTRP trial

A multicenter, open, single-arm, exploratory clinical study of ART002 in the…

ChiCTR2400093099 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2400093099
Public title A multicenter, open, single-arm, exploratory clinical study of ART002 in the treatment of heterozygous familial hypercholesterolemia
Scientific title A multicenter, open, single-arm, exploratory clinical study of ART002 in the treatment of heterozygous familial hypercholesterolemia
Primary sponsor The First Affiliated Hospital of Bengbu Medical College
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions heterozygous familial hypercholesterolaemia
Interventions Dose-escalation group 1:ART002: 0.3mg/kg, single administration;Dose-escalation group 2:ART002: 0.75mg/kg, single administration;Dose-escalation group 3:ART002: 1.0mg/kg, single administration;Dose-escalation group 4:ART002: 1.25mg/kg…
Registration date Nov 28, 2024
Target size Dose-escalation group 1:3;Dose-escalation group 2:3;Dose-escalation group…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations